Staphylococcal protein a, panton-valentine leukocidin and coagulase aggravate the bone loss and bone destruction in osteomyelitis

Cellular Physiology and Biochemistry

Volumn 32, Issue 2, 2013, Pages 322-333

  Jin, Tao ^a,b   Zhu, Yue Liang ^b   Li, Jun ^b   Shi, Jian ^b   He, Xiao Qing ^b   Ding, Jing ^b   Xu, Yong Qing ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

Author keywords

Coagulase; Osteomyelitis; Panton Valentine leukocidin; Protein A; Staphylococcus aureus

Indexed keywords

CALCIUM; CLEAVED CASPASE 3; CLEAVED CASPASE 9; COAGULASE; COLLAGEN TYPE 1; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; PANTON VALENTINE LEUKOCIDIN; PROCASPASE 3; PROCASPASE 9; STAPHYLOCOCCUS PROTEIN A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BONE DESTRUCTION; BONE DEVELOPMENT; BONE MINERALIZATION; BRIGHT FIELD MICROSCOPY; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOMYELITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

ANIMALS; APOPTOSIS; BACTERIAL TOXINS; BONE RESORPTION; CALCIFICATION, PHYSIOLOGIC; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; COAGULASE; EXOTOXINS; GENE EXPRESSION REGULATION; LEUKOCIDINS; MICE; OSTEOBLASTS; OSTEOMYELITIS; STAPHYLOCOCCAL PROTEIN A;

EID: 84885585383     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354440     Document Type: Article

References (42)

1. Martin TJ, Sims NA: Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 2005;11:76-81.
2. Millan JL: The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int 2013, in press.
3. Niu LN, Jiao K, Ryou H, Yiu CK, Chen JH, Breschi L, Arola DD, Pashley DH, Tay FR: Multiphase intrafibrillar mineralization of collagen. Angew Chem Int Ed Engl 2013;52:5762-5766.
4. Bondarenko A, Angrisani N, Meyer-Lindenberg A, Seitz JM, Waizy H, Reifenrath J: Magnesium-based bone implants: Immunohistochemical analysis of peri-implant osteogenesis by evaluation of osteopontin and osteocalcin expression. J Biomed Mater Res A 2013; doi: 10.1002/jbm.a.34828.
5. Ribeiro N, Sousa SR, Monteiro FJ: Influence of crystallite size of nanophased hydroxyapatite on fibronectin and osteonectin adsorption and on mc3t3-e1 osteoblast adhesion and morphology. J Colloid Interface Sci 2010;351:398-406.
6. Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H: Evidence for osteocyte regulation of bone homeostasis through rankl expression. Nat Med 2011;17:1231-1234.
7. Garzoni C, Kelley WL: Staphylococcus aureus: New evidence for intracellular persistence. Trends Microbiol 2009;17:59-65.
8. Lew DP, Waldvogel FA: Osteomyelitis. Lancet 2004;364:369-379.
9. Klosterhalfen B, Peters KM, Tons C, Hauptmann S, Klein CL, Kirkpatrick CJ: Local and systemic inflammatory mediator release in patients with acute and chronic posttraumatic osteomyelitis. J Trauma 1996;40:372-378.
10. Marriott I, Gray DL, Tranguch SL, Fowler VG Jr, Stryjewski M, Scott Levin L, Hudson MC, Bost KL: Osteoblasts express the inflammatory cytokine interleukin-6 in a murine model of staphylococcus aureus osteomyelitis and infected human bone tissue. Am J Pathol 2004;164:1399-1406.
11. Carek PJ, Dickerson LM, Sack JL: Diagnosis and management of osteomyelitis. Am Fam Physician 2001;63:2413-2420.
12. Dhanoa A, Singh VA, Mansor A, Yusof MY, Lim KT, Thong KL: Acute haematogenous community-acquired methicillin-resistant staphylococcus aureus osteomyelitis in an adult: Case report and review of literature. BMC Infect Dis 2012;12:270.
13. Rao N, Ziran BH, Lipsky BA: Treating osteomyelitis: Antibiotics and surgery. Plast Reconstr Surg 2011;127:177S-187S.
14. Zuluaga AF, Galvis W, Saldarriaga JG, Agudelo M, Salazar BE, Vesga O: Etiologic diagnosis of chronic osteomyelitis: A prospective study. Arch Intern Med 2006;166:95-100.
15. Wright JA, Nair SP: Interaction of staphylococci with bone. Int J Med Microbiol 2010;300:193-204.
16. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF: Community-associated meticillin-resistant staphylococcus aureus. Lancet 2010;375:1557-1568.
17. Tenover FC, Goering RV: Methicillin-resistant staphylococcus aureus strain usa300: Origin and epidemiology. J Antimicrob Chemother 2009;64:441-446.
18. Foster TJ: Colonization and infection of the human host by staphylococci: Adhesion, survival and immune evasion. Vet Dermatol 2009;20:456-470.
19. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, Nesme X, Etienne J, Vandenesch F: Relationships between staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 2002;70:631-641.
20. Begun J, Sifri CD, Goldman S, Calderwood SB, Ausubel FM: Staphylococcus aureus virulence factors identified by using a high-throughput caenorhabditis elegans-killing model. Infect Immun 2005;73:872-877.
21. Zecconi A, Scali F: Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases. Immunol Lett 2013;150:12-22.
22. Lofblom J, Kronqvist N, Uhlen M, Stahl S, Wernerus H: Optimization of electroporation-mediated transformation: Staphylococcus carnosus as model organism. J Appl Microbiol 2007;102:736-747.
23. Stoll H, Dengjel J, Nerz C, Gotz F: Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect Immun 2005;73:2411-2423.
24. Merino N, Toledo-Arana A, Vergara-Irigaray M, Valle J, Solano C, Calvo E, Lopez JA, Foster TJ, Penades JR, Lasa I: Protein a-mediated multicellular behavior in staphylococcus aureus. J Bacteriol 2009;191:832-843.
25. Arnaud M, Chastanet A, Debarbouille M: New vector for efficient allelic replacement in naturally nontransformable, low-gc-content, gram-positive bacteria. Appl Environ Microbiol 2004;70:6887-6891.
26. Murphy CM, Haugh MG, O'Brien FJ: The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 2010;31:461-466.
27. Plunkett NA, Partap S, O'Brien FJ: Osteoblast response to rest periods during bioreactor culture of collagen-glycosaminoglycan scaffolds. Tissue Eng Part A 2010;16:943-951.
28. Tuchscherr L, Medina E, Hussain M, Volker W, Heitmann V, Niemann S, Holzinger D, Roth J, Proctor RA, Becker K, Peters G, Loffler B: Staphylococcus aureus phenotype switching: An effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 2011;3:129-141.
29. Tuchscherr L, Heitmann V, Hussain M, Viemann D, Roth J, von Eiff C, Peters G, Becker K, Loffler B: Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis 2010;202:1031-1040.
30. Zhang D, Jiang P, Xu Q, Zhang X: Arginine and glutamate-rich 1 (arglu1) interacts with mediator subunit 1 (med1) and is required for estrogen receptor-mediated gene transcription and breast cancer cell growth. J Biol Chem 2011;286:17746-17754.
31. Tsao FH, Xiang Z, Abbasi A, Meyer KC: Neutrophil necrosis and annexin 1 degradation associated with airway inflammation in lung transplant recipients with cystic fibrosis. BMC Pulm Med 2012;12:44.
32. Tong X, Lin S, Fujii M, Hou DX: Echinocystic acid induces apoptosis in hl-60 cells through mitochondriamediated death pathway. Cancer Lett 2004;212:21-32.
33. Cedergren L, Andersson R, Jansson B, Uhlen M, Nilsson B: Mutational analysis of the interaction between staphylococcal protein a and human igg1. Protein Eng 1993;6:441-448.
34. O'Seaghdha M, van Schooten CJ, Kerrigan SW, Emsley J, Silverman GJ, Cox D, Lenting PJ, Foster TJ: Staphylococcus aureus protein a binding to von willebrand factor a1 domain is mediated by conserved igg binding regions. FEBS J 2006;273:4831-4841.
35. Gomez MI, O'Seaghdha M, Magargee M, Foster TJ, Prince AS: Staphylococcus aureus protein a activates tnfr1 signaling through conserved igg binding domains. J Biol Chem 2006;281:20190-20196.
36. Viau M, Zouali M: Effect of the b cell superantigen protein a from s. Aureus on the early lupus disease of (nzbxnzw) f1 mice. Mol Immunol 2005;42:849-855.
37. Gomez MI, Seaghdha MO, Prince AS: Staphylococcus aureus protein a activates tace through egfrdependent signaling. EMBO J 2007;26:701-709.
38. Kaneko J, Kamio Y: Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: Structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 2004;68:981-1003.
39. Vanassche T, Verhaegen J, Peetermans WE, Hoylaerts MF, Verhamme P: Dabigatran inhibits staphylococcus aureus coagulase activity. J Clin Microbiol 2010;48:4248-4250.
40. MacKenzie SH, Clark AC: Death by caspase dimerization. Adv Exp Med Biol 2012;747:55-73.
41. Hill PA: Bone remodelling. Br J Orthod 1998;25:101-107.
42. Boyce BF, Xing L: Functions of rankl/rank/opg in bone modeling and remodeling. Arch Biochem Biophys 2008;473:139-146.